Immix Biopharma, Inc. (IMMX)
14.07
-0.40
(-2.76%)
USD |
NASDAQ |
Aug 26, 16:00
14.50
+0.43
(+3.06%)
After-Hours: 20:00
Immix Biopharma 1 Year Total Returns (Daily) : 563.7% for Aug. 26, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 26, 2026 | 563.7% |
| August 25, 2026 | 589.0% |
| August 24, 2026 | 521.5% |
| August 21, 2026 | 499.1% |
| August 20, 2026 | 500.9% |
| August 19, 2026 | 502.3% |
| August 18, 2026 | 413.5% |
| August 17, 2026 | 399.6% |
| August 14, 2026 | 400.9% |
| August 13, 2026 | 368.7% |
| August 12, 2026 | 394.3% |
| August 11, 2026 | 395.3% |
| August 10, 2026 | 323.8% |
| August 07, 2026 | 306.7% |
| August 06, 2026 | 287.7% |
| August 05, 2026 | 234.7% |
| August 04, 2026 | 267.3% |
| August 03, 2026 | 217.7% |
| July 31, 2026 | 205.9% |
| July 30, 2026 | 210.9% |
| July 29, 2026 | 202.6% |
| July 28, 2026 | 210.3% |
| July 27, 2026 | 220.7% |
| July 24, 2026 | 205.4% |
| July 23, 2026 | 203.4% |
| Date | Value |
|---|---|
| July 22, 2026 | 230.2% |
| July 21, 2026 | 220.1% |
| July 20, 2026 | 196.3% |
| July 17, 2026 | 251.0% |
| July 16, 2026 | 241.0% |
| July 15, 2026 | 281.5% |
| July 14, 2026 | 269.6% |
| July 13, 2026 | 297.0% |
| July 10, 2026 | 310.0% |
| July 09, 2026 | 303.3% |
| July 08, 2026 | 313.5% |
| July 07, 2026 | 358.8% |
| July 06, 2026 | 309.8% |
| July 02, 2026 | 329.0% |
| July 01, 2026 | 348.9% |
| June 30, 2026 | 398.1% |
| June 29, 2026 | 383.4% |
| June 26, 2026 | 345.5% |
| June 25, 2026 | 338.8% |
| June 24, 2026 | 348.2% |
| June 23, 2026 | 344.4% |
| June 22, 2026 | 319.6% |
| June 18, 2026 | 264.9% |
| June 17, 2026 | 300.4% |
| June 16, 2026 | 264.2% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Savara, Inc. | 69.49% |
| SELLAS Life Sciences Group, Inc. | 654.4% |
| Atossa Therapeutics, Inc. | -77.21% |
| Marker Therapeutics, Inc. | 45.00% |
| Krystal Biotech, Inc. | 144.9% |